Literature DB >> 2527815

Interleukin 5 is a differentiation factor for cytotoxic T lymphocytes.

T Ramos1.   

Abstract

The role of IL-5 on the generation of cytotoxic T lymphocytes (CTL) was analysed using a culture system in which production of T helper cell factors was abrogated by exposure of the stimulator cells to ultraviolet irradiation. Supernatants from a T helper cell line (2.19 sup), recombinant (r) IL-2, rIL-4 and rIL-5 were then tested for the capacity to replace T cell help, on the generation of CTL. The results showed that the specific CTL response, in unseparated spleen cells, could be reconstituted by either 2.19 sup, IL-2 or IL-4. However, if the responder cells were purified in nylon wool, only 2.19 sup or rIL-4 plus rIL-5, but not each lymphokine per se, reconstituted the CTL response. Because IL-5 does not support T cell proliferation, it is suggested that IL-5 induces differentiation of immature precursors into CTL. Based on these findings and in an attempt to conciliate the conflicting views that have emerged from different reports, as to whether IL-2 by itself could support generation of CTL in purified T cells, a hypothesis is formulated, suggesting that T cell at different stages of differentiation require distinct lymphokines to acquire CTL effector function.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2527815     DOI: 10.1016/0165-2478(89)90020-5

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  2 in total

1.  Monitoring of CD4+ and CD8+ T-cell responses after dendritic cell-based immunotherapy using CFSE dye dilution analysis.

Authors:  Thomas Putz; Reinhold Ramoner; Hubert Gander; Andrea Rahm; Georg Bartsch; Lorenz Höltl; Martin Thurnher
Journal:  J Clin Immunol       Date:  2004-11       Impact factor: 8.317

2.  Anti-tumor effects of interleukin-4 and interleukin-5 against mouse B cell lymphoma and possible mechanisms of their action.

Authors:  H K Wu; H Hirai; K Inamori; K Kitamura; F Takaku
Journal:  Jpn J Cancer Res       Date:  1992-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.